- HealthTech
- Tuesday, 09 Jun 2020
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
The new clinical manufacturing facility will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions. The 66,000-square-foot facility is expected to become operational in late 2020 and will bring in up to 100 jobs to the region.
This news follows WuXi Biologics' recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab in King of Prussia, Pennsylvania.
"We are excited to announce our third site in the United States and proud to become a member of the New Jersey community. Cranbury is a growing hub for the biotech and biopharma industries, and we look forward to working with and serving our partners in the area to benefit patients worldwide," said Dr. Chris Chen, CEO of WuXi Biologics.
Related Industry Updates
North America PACS and RIS Market 2020 Global Industry Analysis, Size, Investment Analysis, Trends, Growth, Development Factors, Future Scope, Challenges and 2027 Forecast Research Report
Jan 06, 2021
Comprehensive outlook and valuable analysis on how the COVID-19 impacts the North America Restorative Dentistry Market 2019-2027 | Danaher, 3M, Dentsply Sirona, Brasseler USA
Sep 11, 2020
Patient Monitoring will boost the IoT in Healthcare
Aug 20, 2019
Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market Study Offering Deep Insight Related to Growth Trends Until 2027
Oct 24, 2020
South and Central America Medical Writing Market 2025 In-Depth Coverage and Various Important Aspects of Covid 19 Outbreak Impact: AMAG Technology,Assa Abloy,ATG Access Ltd,Gallagher Group Limited,Honeywell International Inc,Identiv, Inc,Johnson Controls, plc,NEC Corporation,Schneider Electric
Apr 15, 2021
2-1-1 Gives Uninsured Residents Access to Medical Advice
Apr 28, 2020
US Prostate Cancer Nuclear Medicine Diagnostics Market to Witness Healthy Growth with a Significant Rise in Adoption of Pharmaceuticals Technology
Mar 26, 2021
Follow us on
